Sencilia has been gaining traction on the market, and has been the recipient of several awards and competitive Dutch and European grants since its inception.
Stay tuned for updates as we continue on our mission to make IV infusion therapy safer for patients!
Announcements
- By Amar
We are happy to share that Sencilia has been chosen to be one of the...
- By Amar
We are thrilled to announce the successful funding of our project SmartInfuus in collaboration with...
- By Amar
A world renowned clinical expert in neonatal vascular access Roland s reputation as a researcher...